Table 2. Clinical and pathologic characteristics of the 12 cases with no ctDNA alterations detected.
| Case number | Histology | Stage at Diagnosis | Location of tumor(s) | Small volume disease? | Other pathologic features | On therapy at time of blood draw? |
|---|---|---|---|---|---|---|
| 1 | Lung Adenocarcinoma | IIIB | Thoracic only | N | None | Y |
| 5 | NSCLC | IV | Thoracic only | N | Mucinous | N |
| 6 | NSCLC | IA | Thoracic only | Y | None | N |
| 7 | NSCLC | IV | Isolated leptomeningeal disease | N | None | N |
| 8 | NSCLC | IV | Thoracic only | N | None | Y |
| 9 | NSCLC | IIB | Thoracic + brain | Y | Lepidic | Y |
| 10 | NSCLC | IIA | Thoracic only | N | Lepidic | N |
| 11 | NSCLC | IVB | Bone | Y | None | N |
| 61 | NSCLC | IV | Thoracic only | Y | Lepidic | N |
| 70 | Lung Squamous Cell Carcinoma | IA | Thoracic only | Y | None | N |
| 73 | Lung Adenocarcinoma | IV | Thoracic only | N | Lepidic, mucinous | N |
| 82 | Lung Adenocarcinoma | IV | Thoracic only | Y | None | N |
NSCLC, non-small cell lung cancer.